Evidence map›Paper›PMID 27708190›Full record

ArticleThe American journal of tropical medicine and hygiene2016

Plasmodium vivax Landscape in Brazil: Scenario and Challenges.

Andre M Siqueira, Oscar Mesones-Lapouble, Paola Marchesini, Vanderson de Souza Sampaio, Patricia Brasil, Pedro L Tauil, Cor Jesus Fontes, Fabio T M Costa, Cláudio Tadeu Daniel-Ribeiro, Marcus V G Lacerda and 2 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Pediatric MixedChildren (Basel, Switzerland) · 2026
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Accelerating towardsLancet regional health. Americas · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Short-Time Recurrences ofInternational journal of environmental research and public health · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andre M SiqueiraPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Oscar Mesones-LapoublePan American Health Organization, Brasilia, Brazil.
Paola MarchesiniCoordenação Geral do Programa Nacional de Controle da Malaria, Ministério da Saúde, Brasilia, Brazil.
Vanderson de Souza SampaioFundação de Vigilância em Saúde, Manaus, Brazil.
Patricia BrasilInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Pedro L TauilNúcleo de Medicina Tropical, Universidade de Brasília, Brasilia, Brazil.
Cor Jesus FontesUniversidade Federal do Mato Grosso, Cuiabá, Brazil.
Fabio T M CostaUniversidade Estadual de Campinas, Campinas, Brazil.
Cláudio Tadeu Daniel-RibeiroInstituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Marcus V G LacerdaInstituto Leônidas e Maria Deane, Fundação Oswaldo Cruz (Fiocruz), Manaus, Brazil.
Camila P DamascenoCoordenação Geral do Programa Nacional de Controle da Malaria, Ministério da Saúde, Brasilia, Brazil.
Ana Carolina S SantelliCoordenação Geral do Programa Nacional de Controle da Malaria, Ministério da Saúde, Brasilia, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil is the largest country of Latin America, with a considerable portion of its territoritory within the malaria-endemic Amazon region in the North. Furthermore, a considerable portion of its territory is located within the Amazon region in the north. As a result, Brazil has reported half of the total malaria cases in the Americas in the last four decades. Recent progress in malaria control has been accompanied by an increasing proportion of Plasmodium vivax, underscoring a need for a better understanding of management and control of this species and associated challenges. Among these challenges, the contribution of vivax malaria relapses, earlier production of gametocytes (compared with Plasmodium falciparum), inexistent methods to diagnose hypnozoite carriers, and decreasing efficacy of available antimalarials need to be addressed. Innovative tools, strategies, and technologies are needed to achieve further progress toward sustainable malaria elimination. Further difficulties also arise from dealing with the inherent socioeconomic and environmental particularities of the Amazon region and its dynamic changes.

Indexed as

Plasmodium vivaxAntimalarialsBrazilDisease OutbreaksDrug ResistanceHumansIncidenceMalaria, FalciparumMalaria, VivaxPlasmodium falciparumPopulation SurveillanceSpecies SpecificityTime FactorsAntimalarials

Identifiers

PMID27708190
PMCPMC5201227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.